Skip to main content

Oncology Startups

Updated November 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 313 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
313
Total Funding
$2.7B
Avg Funding
$106.8M
Global Reach
7
countries

Top Cities for Oncology

Fort Worth
Menlo Park
New York
Dallas
Boston
San Carlos

Recently Funded Companies

Export
Fort Worth, United States

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

$11.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Hexagon Bio discovers and develops new cancer therapies using microbial natural products, genomic data, and artificial intelligence.

$62.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Pathos applies artificial intelligence, patient data analysis, and biological modeling to drug discovery and clinical development.

$237.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

New York, United States

OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.

$7.2M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Dallas, United States

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

$4.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

$110.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Carlos, United States

ZAP Surgical Systems is a medical company that designs and manufactures a radiosurgery platform for treating brain tumors.

$11.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Ingatestone, United Kingdom

Big Picture Bio is a developer of an AI-driven platform designed to identify, design, and optimize cancer combination therapies.

$2.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Hong Kong, Hong Kong

Connexus Therapeutics is a private, venture-backed biotechnology startup.

$5.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Carlsbad, United States

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

$400.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Paris, France

One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.

$3.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Treating the seeds of cancer

$949K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

$66.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.

$62.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

$225.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.

$1.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Nashville, United States

Thyme Care provides value-based oncology management services designed to coordinate care for individuals diagnosed with cancer.

$125.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Andover, United States

Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.

$1.8M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Axiom Therapeutics is a health tech company that provides computational drug discovery solutions for untreatable cancers.

$12.3M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

$240.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Sydney, Australia

AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.

$315.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.

$1.1M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Erasca is a developer of oncology drugs intended to provide precision oncology options.

$632.5M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Harley, United Kingdom

Leo Cancer Care develops radiation therapy technologies that support cancer treatment in an upright patient position.

$65.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

$67.4M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 313 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 313 oncology companies tracked in the VCBacked database.

Average Funding
$106.8M
Total Funding Tracked
$2.7B
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.New York
2 companies$244.2M
2.Boston
2 companies$335.0M
3.San Diego
2 companies$698.5M
4.Fort Worth
1 companies$11.0M
5.Menlo Park
1 companies$62.0M

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked